Scott Whitaker, the CEO of the industry lobby AdvaMed, told the Senate Finance Committee that he fears tariffs will only raise the cost of care and put patients at risk if companies are unable to overcome supply chain disruptions.
Scott Whitaker, the CEO of the industry lobby AdvaMed, told the Senate Finance Committee that he fears tariffs will only raise the cost of care and put patients at risk if companies are unable to overcome supply chain disruptions.